Food and Drug Administration (FDA) has approved four GLP-1 drugs for weight loss in people with overweight or obesity: liraglutide (Saxenda) orforglipron (Foundayo) semaglutide (Wegovy) tirzepatide (Zepound) Liraglutide, semaglutide, and tirzepatide are injectable medications that come in prefilled pens
The finding was striking
Alternative solutions, such as Canadian pharmacy products or compounded medications from med spas, sometimes offer savings, but there may be safety or efficacy concerns compared to the name-brand medications
This type of multi-system medical improvement was previously only achievable through bariatric surgery
The TrimRx Difference: More Than Just a Prescription While the science of GLP-1 is powerful, the path to success is about more than just medication
Follow-up visits typically occur every 2 to 4 weeks to track your progress, adjust your treatment as needed, and offer continued support